Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 17 May 23 424B3 Prospectus supplement
- 28 Apr 23 EFFECT Notice of effectiveness
-
24 Apr 23 S-3/A Shelf registration (amended)
- 11 Apr 23 S-3 Shelf registration
XXII similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-3 filed on April 24, 2023 of 22nd Century Group, Inc. of our report dated July 19, 2022 relating to the combined consolidated financial statements of GVB Biopharma incorporated by reference in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the captions "Experts".
Armanino LLP
/s/ Armanino LLP
Woodland Hills, California
April 24, 2023